Category: Cerebrovascular Disease

Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain

Posted on | Posted on John Murphy | Leave a Comment on Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain

Héctor Hernández-Parra1,2 Octavio Daniel Reyes-Hernández3 Gabriela Figueroa-González4 Manuel González-Del Carmen5 Maykel González-Torres6 Sheila I. Peña-Corona2 Benjamín Florán7 Hernán Cortés8* Gerardo Leyva-Gómez2* https://pubmed.ncbi.nlm.nih.gov/36998270/ Diverse neurological symptoms have been reported in patients with SARS-CoV-2 disease (COVID-19), including stroke, ataxia, meningitis, encephalitis, and cognitive impairment. These alterations can cause serious sequelae or death and are associated with the entry of SARS-CoV-2 into the Central Nervous System […]

Opinions | How long covid reshapes the brain — and how we might treat it

Posted on | Posted on John Murphy | Leave a Comment on Opinions | How long covid reshapes the brain — and how we might treat it

Authors: Wes Ely August 25, 2022 The Washington Post The young man pulled something from behind both ears. “I can’t hear anything without my new hearing aids,” said the 32-year-old husband and father. “My body is broken, Doc.” Once a fireman and emergency medical technician, he’d had covid more than 18 months before and was nearly […]

How COVID Could Screw You Worse With Each Reinfection

Posted on | Posted on John Murphy | Leave a Comment on How COVID Could Screw You Worse With Each Reinfection

Authors: David Axe Tue, July 5, 2022 The more times you catch COVID, the sicker you’re likely to get with each reinfection. That’s the worrying conclusion of a new study drawing on data from the U.S. Veterans Administration. Scientists stressed they need more data before they can say for sure whether, and why, COVID might get worse […]

Alzheimer’s-like signaling in brains of COVID-19 patients

Posted on | Posted on John Murphy | Leave a Comment on Alzheimer’s-like signaling in brains of COVID-19 patients

Authors: Steve Reiken,Leah Sittenfeld,Haikel Dridi,Yang Liu,Xiaoping Liu,Andrew R. Marks First published: 03 February 2022  https://doi.org/10.1002/alz.12558 Abstract Introduction The mechanisms that lead to cognitive impairment associated with COVID-19 are not well understood. Methods Brain lysates from control and COVID-19 patients were analyzed for oxidative stress and inflammatory signaling pathway markers, and measurements of Alzheimer’s disease (AD)-linked […]

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Posted on | Posted on John Murphy | Leave a Comment on Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Authors:  Bhavana Kunkalikar Mar 24 2022 Reviewed by Danielle Ellis, B.Sc. BioRxiv A recent study posted to the bioRxiv* preprint server assessed the uptake of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein in human cerebrovascular cells via the lipid raft ganglioside.   Various studies have reported the effects of coronavirus disease 2019 (COVID-19) on […]

COVID-19 and cerebrovascular diseases: a comprehensive overview

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 and cerebrovascular diseases: a comprehensive overview

Authors: Georgios Tsivgoulis, Lina Palaiodimou, Ramin Zand First Published December 8, 2020 Review Article Find in PubMed https://doi.org /10.1177/1756286420978004 Abstract Neurological manifestations are not uncommon during infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A clear association has been reported between cerebrovascular disease and coronavirus disease 2019 (COVID-19). However, whether this association is causal or incidental is […]

Age- and Sex-Specific Incidence of Cerebral Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination

Posted on | Posted on John Murphy | Leave a Comment on Age- and Sex-Specific Incidence of Cerebral Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination

Authors: Aneel A. Ashrani, MD, MS1; Daniel J. Crusan, BS2; Tanya Petterson, MS2; et al JAMA Intern Med. 2022;182(1):80-83. doi:10.1001/jamainternmed.2021.6352 Recent reports1–4 suggest a possible association between Ad26.COV2.S (Johnson & Johnson/Janssen) COVID-19 vaccination and cerebral venous sinus thrombosis (CVST). Estimates of postvaccination CVST risk require accurate age- and sex-specific prepandemic CVST incidence rates; however, reported rates vary widely.5 We compared the age- and sex-specific CVST rates after […]

Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis

Posted on | Posted on John Murphy | Leave a Comment on Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis

Authors: Xinyang Li, Xianrui Zhong, Yongbo Wang, Xiantao Zeng, Ting Luo, Qing Liu  Published: May 3, 2021 Abstract Objective We aimed to systematically identify the possible risk factors responsible for severe cases. Methods We searched PubMed, Embase, Web of science and Cochrane Library for epidemiological studies of confirmed COVID-19, which include information about clinical characteristics […]

Neurologic Manifestations Associations of COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Neurologic Manifestations Associations of COVID-19

High-quality epidemiologic data is still urgently needed to better understand neurologic effects of COVID-19. Authors: Shraddha Mainali, MD; and Marin Darsie, MD VIEW/PRINT PDF Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continues to prevail as a deadly pandemic and unparalleled global crisis. More than 74 million people have been infected globally, and over 1.6 […]

Potential mechanisms of cerebrovascular diseases in COVID-19 patients

Posted on | Posted on John Murphy | Leave a Comment on Potential mechanisms of cerebrovascular diseases in COVID-19 patients

Authors: Manxue Lou 1, Dezhi Yuan 2 3, Shengtao Liao 4, Linyan Tong 1, Jinfang Li 5Affiliations expand Abstract Since the outbreak of coronavirus disease 2019 (COVID-19) in 2019, it is gaining worldwide attention at the moment. Apart from respiratory manifestations, neurological dysfunction in COVID-19 patients, especially the occurrence of cerebrovascular diseases (CVD), has been intensively investigated. In this review, the effects of COVID-19 infection on […]